Agreed to the above post...
If you haven't already entered, it's likely an extremely high-risk long. The short interest I read was 19% ([buy] covers for the short), and it's at 16% gain as of now. I don't know how much further it will go before it loses it's steam and plummet again.
There are other pharmaceuticals with higher return vs. risk..







